MAIA Biotechnology Inc
For the period ended Dec 31, 2023. Filed Mar 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 21, 2024
MAIA$1.09+2.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Net loss | $(19,772,905) | $(16,219,857) |
| Foreign currency translation adjustment | (287) | (15,973) |
| Comprehensive loss | $(19,773,192) | $(16,235,830) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.